Title | Creator | Relation Is Part Of | ||
---|---|---|---|---|
1 |
![]() | CHAMPS (the Controlled High Risk Avonex Multiple Sclerosis trial) Update | Steven L. Galetta, MD | NANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium |
2 |
![]() | Contemporary and New Immunomodulatory Therapy for Multiple Sclerosis | Richard A. Rudick | NANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium |
3 |
![]() | Evolving Concepts in the Pathogenesis of Multiple Sclerosis | Richard A. Rudick | NANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium |
4 |
![]() | Historical Perspective on the Diagnosis and Treatment of Optic Neuritis | Nicholas J. Volpe | NANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium |
5 |
![]() | Neuromyelitis Optica | Eric R. Eggenberger, DO | NANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium |
6 |
![]() | New Imaging Techniques in Multiple Sclerosis | Robert I. Grossman | NANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium |
7 |
![]() | ONTT (Optic Neuritis Treatment Trial) Update | Craig H. Smith, MD | NANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium |
8 |
![]() | Outcome Measures in Clinical Trials in Multiple Sclerosis | Laura J. Balcer | NANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium |